Moving from RCTs to innovative methodologies in real world evidence
Why does RWE matter? Because outcomes matter! As a pioneer in real-world evidence (RWE) in diabetes, Sanofi has been building a large set of real world data for its insulins. Medical outcomes are defined by the relationship that exists between patient biology, patient behavior and healthcare practices. It is through RWE that we are able to gain a fuller picture of how our interventions truly affect those outcomes in real life. Sanofi’s RWE program contributes to the continuum of clinical research bridging the gap between randomized controlled trials (RCTs) and real life.